Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral etoposide maintenance after EP induction for extensive-stage small cell lung cancer
ChiCTR-TNC-09000357Phase 2Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of etoposide in small cell lung cancer (SCLC), sponsored by West China Hospital of Sichuan University. Primary endpoints: Grade 4 toxicities and Progression-free survival. Started Apr 2009; status: completed.
02
Drugs
etoposide
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on ChiCTR-TNC-09000357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TNC-09000357.